Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

SELL
$0.58 - $1.3 $277 - $621
-478 Reduced 28.95%
1,173 $1,000
Q1 2023

Apr 27, 2023

SELL
$1.09 - $1.82 $2,053 - $3,428
-1,884 Reduced 53.3%
1,651 $2,000
Q4 2022

Feb 07, 2023

SELL
$1.52 - $3.39 $299 - $667
-197 Reduced 5.28%
3,535 $5,000
Q2 2022

Aug 12, 2022

SELL
$1.6 - $5.07 $2,195 - $6,956
-1,372 Reduced 26.88%
3,732 $7,000
Q1 2022

May 04, 2022

SELL
$3.92 - $5.86 $1,113 - $1,664
-284 Reduced 5.27%
5,104 $22,000
Q4 2021

Feb 07, 2022

SELL
$5.0 - $14.85 $9,950 - $29,551
-1,990 Reduced 26.97%
5,388 $29,000
Q3 2021

Nov 02, 2021

BUY
$12.13 - $16.99 $89,495 - $125,352
7,378 New
7,378 $101,000

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.